Clinical Trials Sponsored by BrainCool AB

Total 988 results

Gedea Biotech AB

Completed

Clinical Performance of a Vaginal Pessary (pHyph) in Vulvovaginal Candidiasis

Vulvovaginal Candidiasis

Sweden
Modus Therapeutics AB

Completed

Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin

Safety and Tolerability

United States
Corline Biomedical AB

Unknown

Heparinized Islets in Clinical Islet Transplantation

Type 1 Diabetes Mellitus

Sweden
AB Biotics, SA

Completed

A Trial to Evaluate the Efficacy of AB-Life Probiotic Product on LDL-Cholesterol Reduction in Moderate Hypercholesterolemia

Moderate Hypercholesterolemia

France
Vivolux AB
Theradex

Terminated

A Study of VLX1570 and Dexamethasone in Myeloma Patients

Multiple Myeloma

United States
Moberg Pharma AB

Completed

A Study of the Systemic Absorption of MOB015B

Onychomycosis

United States
Occlutech International AB

Completed

Prospective, Non-randomized, Safety and Efficacy Study of a New Occluder Design for Minimally Invasive Closure of the Left Atrial Appendage (LAA) in Patients With Atrial Fibrillation (OLAAC)

Atrial Fibrillation

Germany, United Kingdom
RSPR Pharma AB

Completed

Safety and Efficacy of CRD007 in Adult Asthma Subjects

Asthma

Denmark, Poland, Bulgaria, United Kingdom
RSPR Pharma AB

Completed

RSPR-007 Mannitol Challenge Trial

Asthma

Denmark
Newron Sweden AB

Terminated

A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031.

Parkinson's Disease

Sweden
RSPR Pharma AB

Completed

Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast

Healthy Volunteers
PepTonic Medical AB

Completed

A Pharmacokinetic Study of Vaginally and Intravenously Administered Oxytocin

Vaginal Atrophy

Sweden
Tigran Technologies AB

Completed

Reconstruction of Peri-implant Osseous Defects: A Randomized Trial

Peri-implantitis

Sweden
Moberg Pharma AB

Completed

An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)

Distal Subungual Onychomycosis

Sweden
Active Biotech AB

Completed

ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States, Denmark, Russian Federation
Axcentua Pharmaceuticals AB

Unknown

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Adenocarcinoma

Sweden
Swedish Match AB

Completed

Serbian Smoking Reduction/Cessation Trial (2SRT) (2SRT)

Cigarette Smoking

Serbia
Moberg Pharma AB

Completed

Efficacy and Safety of a New Topical Formulation With Imiquimod (Limtop) Applied 1, 3 or 7 Times Weekly During 2 x 2 Weeks Treatment for Actinic Keratosis on the Head

Actinic Keratosis

Germany
RSPR Pharma AB

Completed

CRD007 for the Treatment of Duchenne Muscular Dystrophy, Becker Muscular Dystrophy and Symptomatic Carriers

Duchenne Muscular Dystrophy | Becker Muscular Dystrophy

Sweden
Moberg Pharma AB

Completed

A Double-blind, Randomized, Single Centre, Vehicle-controlled Study to Evaluate the Safety and Tolerability of a New Topical Formulation Containing 0,09% Imiquimod (Limtop) in Healthy Subjects (Limsafe)

Healthy

Germany
Akloma Bioscience AB

Completed

The Akloma Tinnitus Patch in Patients With Manifested Tinnitus (Aktin)

Tinnitus

Sweden
PepTonic Medical AB

Completed

Study of Oxytocin to Treat Vaginal Atrophy in Postmenopausal Women

Vaginal Atrophy | Postmenopause

Sweden, United Kingdom
Diamyd Therapeutics AB

Completed

Safety of Diamyd® in Patients With LADA (Latent Autoimmune Diabetes in Adult)

Latent Autoimmune Diabetes in Adult (LADA)

Sweden
Moberg Pharma AB

Completed

Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study

Atopic Dermatitis

Germany
Karo Bio AB

Completed

LDL-Cholesterol Lowering Effect of KB2115 as Add on to Statin

Dyslipidemia

Sweden
Karo Bio AB

Completed

LDL-Cholesterol Lowering Effect of KB2115 as Add on to Ezetimibe

Hypercholesterolemia

Sweden
Karo Bio AB

Completed

Eprotirome for the Treatment of Dyslipidemia, Efficacy and Safety 12-Week, Phase ii Study to Assess the Safety and Efficacy of KB2115 in Patients With Primary Hypercholesterolemia

Primary Hypercholesterolemia

Sweden
Karolinska Institutet
Vastra Gotaland Region; SOS Alarm Sverige AB; Everdrone AB; Aviation capacity resources... and other collaborators

Completed

AED-delivery Using Drones in Suspected OHCA

Out-Of-Hospital Cardiac Arrest

Sweden
Spago Nanomedical AB

Recruiting

A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer (Tumorad)

Solid Tumor | Metastatic Cancer | Refractory Cancer | Locally Advanced Solid Tumor | Unresectable Solid Tumor | Recurrent Solid Tumor

Australia
Sigrid Therapeutics AB

Recruiting

Multicenter Trial Investigating Performance and Safety of the Medical Device SiPore21® (SHINE)

Overweight or Obesity

Slovakia, Poland, Romania
Circius Pharma AB

Recruiting

Performance and Safety of Otinova® Ear Spray

Otitis Externa

Sweden
Occlutech International AB

Recruiting

PMCF Study to Evaluate Efficacy, Safety of the Occlutech PDA Occluder in Patients With Patent Ductus Arteriosus Defects

Patent Ductus Arteriosus

Tunisia, Turkey, Italy, Pakistan, United Kingdom
Occlutech International AB

Recruiting

ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability of Occlutech Accessory Medical Devices

Heart Diseases

Turkey, Germany
Occlutech International AB

Recruiting

Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion (OCCLUFLEX)

Stroke | Patent Foramen Ovale

United States, Denmark, Canada, Netherlands, Germany, United Kingdom, Finland
Diamyd Medical AB

Recruiting

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

Type 1 Diabetes Mellitus

Czechia, Spain, United States, Hungary, Netherlands, Estonia, Germany, Poland, Sweden
BioInvent International AB

Recruiting

A Study of BI-1206 in Combination With Rituximab in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma

Indolent B-Cell Non-Hodgkin Lymphoma

Spain, United States, Brazil, Sweden, Germany, Poland
Hamlet Pharma AB

Recruiting

A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer

Non-muscle Invasive Bladder Cancer

Czechia
Ostomycure AB
Veranex

Terminated

Safety, Performance and Durability of the TIES® Implant in Patients Requiring a Permanent Ileostomy

Ileostomy - Stoma

United Kingdom, Sweden
AB Biotics, SA

Completed

Prospective Study to Determine the Factors Influencing Infant Colic

Infant Colic

Mexico, Spain
Hansa Biopharma AB

Completed

A Study of Imlifidase in Patients With Guillain-Barré Syndrome

Guillain-Barré Syndrome (GBS)

France, Netherlands, United Kingdom
Occlutech International AB

Active, not recruiting

A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects

Perimembranous Ventricular Septal Defect

Thailand, Germany, Ireland, Vietnam
AB Biotics, SA

Terminated

Effect of Probiotics on Recurrent Urinary Tract Infections (CYSCARE)

Urinary Tract Infections

Spain
Vicore Pharma AB

Completed

A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects (ATTRACT-3)

COVID-19

Philippines, United States, Brazil, India, Russian Federation, Colombia, Argentina, Czechia, South Africa, Ukraine
Bohus Biotech AB

Completed

A Clinical Investigation of the Decoria® Aesthetic Group (DAG) for Correction of Nasolabial Folds (NLF) (Decorate01)

Correction of Nasolabial Folds

Sweden
Kontigo Care AB

Completed

An Explorative Pilot Study of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With SUD

Drug Abuse

Sweden
NextCell Pharma Ab

Completed

Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes

Type1 Diabetes Mellitus

Sweden
Hansa Biopharma AB

Completed

A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

Kidney Transplant Failure and Rejection

United States, Sweden, France
BioInvent International AB

Terminated

A Phase II Study of BI-505 in Smoldering Multiple Myeloma

Smoldering Multiple Myeloma

Sweden
AB Biotics, SA

Terminated

Effect of a Probiotic Formula on Reducing SIBO in IBS Patients

Irritable Bowel Syndrome | Small Intestinal Bacterial Overgrowth

Spain
Gedea Biotech AB

Completed

VVC Sampling Study for Analysis Validation

Vulvovaginal Candidiasis

United Kingdom

3

Subscribe